Pleural effusion: diagnosis, treatment, and management

Vinaya S Karkhanis, Jyotsna M Joshi, Vinaya S Karkhanis, Jyotsna M Joshi

Abstract

A pleural effusion is an excessive accumulation of fluid in the pleural space. It can pose a diagnostic dilemma to the treating physician because it may be related to disorders of the lung or pleura, or to a systemic disorder. Patients most commonly present with dyspnea, initially on exertion, predominantly dry cough, and pleuritic chest pain. To treat pleural effusion appropriately, it is important to determine its etiology. However, the etiology of pleural effusion remains unclear in nearly 20% of cases. Thoracocentesis should be performed for new and unexplained pleural effusions. Laboratory testing helps to distinguish pleural fluid transudate from an exudate. The diagnostic evaluation of pleural effusion includes chemical and microbiological studies, as well as cytological analysis, which can provide further information about the etiology of the disease process. Immunohistochemistry provides increased diagnostic accuracy. Transudative effusions are usually managed by treating the underlying medical disorder. However, a large, refractory pleural effusion, whether a transudate or exudate, must be drained to provide symptomatic relief. Management of exudative effusion depends on the underlying etiology of the effusion. Malignant effusions are usually drained to palliate symptoms and may require pleurodesis to prevent recurrence. Pleural biopsy is recommended for evaluation and exclusion of various etiologies, such as tuberculosis or malignant disease. Percutaneous closed pleural biopsy is easiest to perform, the least expensive, with minimal complications, and should be used routinely. Empyemas need to be treated with appropriate antibiotics and intercostal drainage. Surgery may be needed in selected cases where drainage procedure fails to produce improvement or to restore lung function and for closure of bronchopleural fistula.

Keywords: biopsy; decortication; thoracocentesis; thoracoscopy.

Figures

Figure 1
Figure 1
Causes of pleural effusion. Abbreviations: AAL, amebic abscess of liver; CCF, congestive cardiac failure; LAM, lymphangioleomyomatosis; PCIS, post cardiac injury syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; TB, tuberculosis.
Figure 2
Figure 2
Approach to a patient with pleural effusion.
Figure 3
Figure 3
X-ray chest, posteroanterior view, with Ellis S-shaped curve.
Figure 4
Figure 4
X-ray chest, posteroanterior view, with lamellar effusion.
Figure 5
Figure 5
(A) X-ray chest, posteroanterior view, with fissural effusion, and (B) X-ray chest, lateral view, with fissural effusion.
Figure 6
Figure 6
Computed tomography showing “comet tail” sign.
Figure 7
Figure 7
(A) X-ray chest, posteroanterior view with subpulmonic effusion, and (B) lateral decubitus X-ray showing free fluid.
Figure 8
Figure 8
X-ray chest, posteroanterior view, with massive effusion and contralateral mediastinal shift.
Figure 9
Figure 9
Contrast-enhanced computed tomography: split pleural sign.
Figure 10
Figure 10
Contrast-enhanced computed tomography: Leung’s criteria.,
Figure 11
Figure 11
(A) and (B) methylene blue test.
Figure 12
Figure 12
Chylous fluid.
Figure 13
Figure 13
Management of empyema. Abbreviation: ICD, intercostal drain.
Figure 14
Figure 14
Intercostal drainage with underwater drain using glass bottle.
Figure 15
Figure 15
Intercostal drainage with Urosac bag.
Figure 16
Figure 16
Stoma bag for pleurocutaneous fistula.

References

    1. Collins TR, Sahn SA. Thoracocentesis: clinical value, complications, technical problems and patient experience. Chest. 1987;91:817–822.
    1. Sahn SA, Heffner JE. Approach to the patient with pleurisy. In: Kelly WN, editor. Kelly’s Textbook of Internal Medicine. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins; 1991.
    1. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006;73:1211–1220.
    1. Stelzner TJ, King TE, Antony VB, Sahn SA. Pleuropulmonary manifestations of the postcardiac injury syndrome. Chest. 1983;84:383–387.
    1. Uong V, Nugent K, Alalawi R, Raj R. Amiodarone-induced loculated pleural effusion: case report and review of the literature. Pharmacotherapy. 2010;30:218.
    1. Singh SK, Ahmad Z, Pandey DK, Gupta V, Naaz S. Isoniazid causing pleural effusion. Indian J Pharmacol. 2008;40:87–88.
    1. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med. 2004;25:141–153.
    1. Blesovsky A. The folded lung. Br J Dis Chest. 1966;60:19–22.
    1. Stark P. Round atelectasis: another pulmonary pseudotumor. Am Rev Respir Dis. 1982;125:248–250.
    1. Doyle TC, Lawler GA. CT features of rounded atelectasis of the lung. AJR Am J Roentgenol. 1984;143:225–228.
    1. Byrk D. Infrapulmonary effusions. Radiology. 1976;120:33–36.
    1. Schwarz MI, Marmorstein BL. A new sign of subpulmonic effusion. Chest. 1975;67:176–178.
    1. Gallardo X, Castaner E, Mata JM. Benign pleural diseases. Eur J Radiol. 2000;34:87–97.
    1. Moskowitz H, Platt RT, Schachar R, Mellins H. Roentgen visualization of minute pleural effusion. An experimental study to determine the minimum amount of pleural fluid visible on a radiograph. Radiology. 1973;109:33–35.
    1. Maher GG, Berger HW. Massive pleural effusions: malignant and non-malignant causes in 46 patients. Am Rev Respir Dis. 1972;105:458–460.
    1. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest. 2003;124:978–983.
    1. Pugatch RD, Spirn PW. Radiology of the pleura. Clin Chest Med. 1985;6:17–32.
    1. Yu CJ, Yang PC, Wu HD, Chang DB, Kuo SH, Luh KT. Ultrasound study in unilateral hemithorax opacification. Image comparison with computed tomography. Am Rev Respir Dis. 1993;147:430–434.
    1. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol. 1992;159:29–33.
    1. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J. 1997;10:1150–1156.
    1. Tsai TH, Yang PC. Ultrasound in the diagnosis and management of pleural disease. Curr Opin Pulm Med. 2003;9:282–290.
    1. Yataco JC, Dweik RA. Pleural effusions: Evaluation and management. Cleve Clin J Med. 2005;72:854–866.
    1. Van Sonnenberg E, Nakamoto SK, Mueller PR, et al. CT and ultrasound guided catheter drainage of empyemas after chest tube failure. Radiology. 1984;151:349–353.
    1. Stark DD, Federle MP, Goodman PC, Podrasky AE, Webb WR. Differentiating lung abscess and empyema. AJR Am J Roentgenol. 1983;141:163–167.
    1. Stark DD, Federle MP, Goodman PC. CT and radiographic assessment of tube thoracostomy. Am J Roentgenol. 1983;141:253–258.
    1. Algın O, Gökalp G, Topal U. Signs in chest imaging. Diagn Interv Radiol. 2011;17:18–29.
    1. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990;154:487–492.
    1. Duysinx B, Nguyen D, Louis R, et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging. Chest. 2004;125:489–493.
    1. Duysinx BC, Lorock MP, Nguyen D, et al. 18F-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun. 2006;27:971–976.
    1. Bagga S. Rheumatoid lung disease as seen on PET/CT scan. Clin Nucl Med. 2007;37:753–754.
    1. Orki, Akin O, Tasci AE, et al. The role of positive emission tomography/computed tomography in the diagnosis of pleural diseases. Thorac Cardiovasc Surg. 2009;57:217–221.
    1. Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003;58(Suppl 2):ii8–ii17.
    1. Porcel JM. Pearls and myths in pleural fluid analysis. Respirology. 2011;16:44–52.
    1. Broaddus VC, Light RW. What is the origin of pleural transudates and exudates? Chest. 1992;102:658–659.
    1. Light RW, MacGregor MI, Luchsinger PC, Ball WC., Jr Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–513.
    1. Heffner JE, Brown LK, Barbieri C. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest. 1997;111:970–980.
    1. Mitrouska I, Bouros D. The trans-exudative pleural effusions. Chest. 2002;122:1503–1505.
    1. Romero S, Candela A, Martin C, Hernandez L, Trigo C, Gil J. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest. 1993;104:399–404.
    1. Burgess LJ, Maritz FJ, Taljaard JJ. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest. 1995;107:1604–1609.
    1. Heffner JE. Evaluating diagnostic tests in the pleural space. Differentiating transudates from exudates as a model. Clin Chest Med. 1998;19:277–293.
    1. Light RW, Erozan YS, Ball WC., Jr Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med. 1973;132:854–860.
    1. Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med. 1984;77:915–920.
    1. Ferreiro L, San José E, González-Barcala FJ, et al. Eosinophilic pleural effusion: incidence, etiology and prognostic significance. Arch Bronconeumol. 2011;47:504–509.
    1. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J. 2000;15:166–169.
    1. Sahn SA. Pathogenesis and clinical features of diseases associated with a low pleural fluid glucose. In: Chretien J, Bignon J, Hirsch A, editors. The Pleura in Health and Disease. Volume 30. New York: Marcel Dekker; 1985.
    1. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest. 1975;67:536–539.
    1. Adams RF, Gleeson FV. Percutaneous image-guided cutting-needle biopsy of the pleura in the presence of a suspected malignant effusion. Radiology. 2001;219:510–514.
    1. Abrahms LD. A pleural biopsy punch. Lancet. 1958;1:30–31.
    1. Morrone N, Algranti E, Barreto E. Pleural biopsy with Cope and Abrams needles. Chest. 1987;92:1050–1052.
    1. Mungall IP, Cowen PN, Cooke NT, Roach TC, Cooke NJ. Multiple pleural biopsy with the Abrams needle. Thorax. 1980;35:600–602.
    1. Cowie RL, Escreet BC, Goldstein B, Langton ME, Leigh RA. Pleural biopsy: a report of 750 biopsies performed using Abrams pleural biopsy punch. S Afr Med J. 1983;64:92–95.
    1. Chakrabarti B, Ryland I, Sheard J, Warburton CJ, Earis JE. The role of the Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest. 2006;129:1549–1555.
    1. James P, Gupta R, Christopher DJ, Balamugesh T. Evaluation of the diagnostic yield and safety of closed pleural biopsy in the diagnosis of pleural effusion. Indian J Tuberc. 2010;57:19–24.
    1. Harris RJ, Kavuru MS, Rice TW, Kirby TJ. The diagnostic and therapeutic utility of thoracoscopy. A review. Chest. 1995;108:828–841.
    1. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;1:CD002916.
    1. Tschopp JM, Boutin C, Astoul C, et al. Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomized study. Eur Respir J. 2002;20:1003–1009.
    1. Colt HG. Thoracoscopy. A prospective study of safety and outcome. Chest. 1995;108:324–329.
    1. LeRoux BT. Bronchial carcinoma with pleural effusion. S Afr Med J. 1968;42:865–866.
    1. Heaton RW, Roberts CM. The role of fibreoptic bronchoscopy in the investigation of pleural effusion. Postgrad Med J. 1988;64:581–582.
    1. Berger HW, Mejia E. Tuberculous pleurisy. Chest. 1973;63:88–92.
    1. Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med. 1967;66:972–982.
    1. Hurwitz S, Leiman G, Shapiro C. Mesothelial cells in pleural fluid: TB or not TB? S Afr Med J. 1980;57:937–939.
    1. Jones D, Lieb T, Narita M, Hollender ES, Pitchenik AE, Ashkin D. Mesothelial cells in tuberculous effusions of HIV-infected patients. Chest. 2000;117:289–291.
    1. Heyderman RS, Makunike R, Muza T, et al. Pleural tuberculosis in Harare, Zimbabwe: the relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease. Trop Med Int Health. 1998;3:14–20.
    1. Valdes L, Alvarez D, San Jose E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998;158:2017–2021.
    1. Levine H, Metzger W, Lacera D, Kay L. Diagnosis of tuberculous pleurisy by culture of pleural biopsy specimen. Arch Intern Med. 1970;126:269–271.
    1. Valdes L, San Jose ME, Pose A, et al. Diagnosing tuberculous pleural effusion using clinical data and pleural fluid analysis. A study of patients less than 40 years-old in an area with a high incidence of tuberculosis. Respir Med. 2010;104:1211–1207.
    1. Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J. 1978;2:1751–1752.
    1. Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax. 1995;50:672–674.
    1. Valdes L, Jose ES, Alvarez D, Valle JM. Adenosine deaminase isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Resp J. 1996;9:747–751.
    1. Zemlin AE, Burgess LJ, Carstens ME. The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions. Int J Tuberc Lung Dis. 2009;13:214–220.
    1. Hsu WH, Chiana CD, Huang PL. Diagnostic value of pleural adenosine deaminase in tuberculous effusions of immunocompromised hosts. J Formos Med Assoc. 1993;92:668–670.
    1. Titarenko OT, D’iakova ME, Perova TL, D’iakova AI, Popov MIu. Informative value of adenosine deaminase and 2-deoxyadenosine deaminase in the diagnosis of tuberculous pleurisy. Klin Lab Diagn. 2002;5:11–14. Russian.
    1. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis. 1974;110:56–77.
    1. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3:75–80.
    1. Muduly DK, Deo SVS, Subi TS, Kallianpur AA, Shukla NK. An update in the management of malignant pleural effusion. Indian J Palliat Care. 2011;17:98–103.
    1. Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology. 2007;18:28–32.
    1. Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med. 2000;6:267–274.
    1. Rice TW, Rodriguez RM, Barnette R, Light RW. Prevalence and characteristics of pleural effusions in superior vena cava syndrome. Respirology. 2006;11:299–305.
    1. Qureshi NR, Gleeson FV. Imaging of pleural disease. Clin Chest Med. 2006;27:193–213.
    1. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol. 1990;154:487–492.
    1. Yilmaz U, Polat G, Sachin N, Soy O, Gulay U. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis. 2005;63:17–22.
    1. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol. 2001;56:193–196.
    1. Maskell NA, Gleeson FV, Davis RJ. Standard pleural biopsy versus CT-guided cutting needle biopsy for diagnosis of malignant disease in pleural effusions: a randomized controlled trial. Lancet. 2003;361:1326–1330.
    1. Lee YC, Light RW. Management of malignant pleural effusions. Respirology. 2004;9:148–156.
    1. Sahn SA. Management of malignant pleural effusions. Monaldi Arch Chest Dis. 2001;56:394–399.
    1. Groth G, Gatzemeier U, Haussingen K, et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone) Ann Oncol. 1991;2:213–215.
    1. Antunes G, Neville E, Duffy J, Ali N, BTS Pleural Disease Group, a subcommittee of the BTS Standards of Care Committee, editors. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58:ii29–ii38.
    1. Whitaker D. The cytology of malignant mesothelioma. Cytopathology. 2000;11:139–151.
    1. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol. 1993;24:347–354.
    1. Helmers R, Galvin J, Hunninghake CW. Pulmonary manifestations associated with rheumatoid arthritis. Chest. 1991;100:235–238.
    1. Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine. 1968;47:501–520.
    1. Allen JS, Donahue DM, Garrity JM. Rheumatoid pleural effusion in the absence of arthritic disease. Ann Thorac Surg. 2005;80:1519–1521.
    1. Lillington GA, Carr DT, Mayne JG. Pleurisy with effusion in rheumatoid arthritis with reference to the low concentration of glucose in pleural fluid. Am Rev Respir Dis. 1962;88:345–350.
    1. Dodson WH, Hollingsworth JW. Pleural effusion in rheumatoid arthritis: Impaired transport of glucose. N Engl J Med. 1966;275:1337–1342.
    1. Sahn SA, Kaplan RL, Maulitz RM, Good JT., Jr Rheumatoid pleurisy: observation on the development of low pleural fluid pH and glucose level. Am J Resp Crit Care Med. 1980;140:1237–1238.
    1. Haput HM, Moore WG, Huthin GM. The lung in SLE. Am J Med. 1981;71:791–798.
    1. Good JT, Jr, King TE, Antony VB, Sahn SA. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid anti-nuclear antibody. Chest. 1983;84:714–718.
    1. Ibarra-Perez C. Thoracic complications of amebic abscess of the liver: report of 501 cases. Chest. 1981;79:672–676.
    1. Cameron EWJ. The treatment of pleuropulmonary amebiasis with metronidazole. Chest. 1978;73:647–650.
    1. Vergese M, Eggleston FC, Handa AK, Singh CM. Management of thoracic amebiasis. J Thorac Cardiovasc Surg. 1979;78:757–760.
    1. Rasaretnam R, Paul ATS, Yoganathan M. Pleural empyema due to ruptured amebic liver absecess. Br J Surg. 1974;61:713–715.
    1. Shrinivasan B, Mohite PN, Thingnam SK. Extrapulmonary intrapleural hydatid cysts – rare variant of uncommon disease. Indian J Thorac Cardiovasc Surg. 2010;26:247–250.
    1. Ozvaran MK, Ersoy Y, Uskul B, et al. Pleural complications of pulmonary hydatid disease. Respirology. 2004;9:115–119.
    1. Thameur H, Chenik S, Abdelmoulah S, et al. Thoracic hydatidosis. A review of 1619 cases. Rev Pneumol Clin. 2000;56:7–15.
    1. Kaye MD. Pleuropulmonary complications of pancreatitis. Thorax. 1968;23:297–305.
    1. Anderson WJ, Skinner DB, Zuidema GD, Cameron DL. Chronic pancreatic pleural effusions. Surg Gynecol Obstet. 1973;137:827–830.
    1. Tabor E, Russell RP, Gerety RJ, Barker LF, Hillis WD, Jackson DR. Hepatitis B surface antigen and e antigen in pleural effusion: A case report. Gastroenterology. 1977;73:1157–1159.
    1. Sahn SA. State of the art: the pleura. Am Rev Respir Dis. 1988;138:184–234.
    1. DeMeester T. The pleura. In: Spenser E, editor. Surgery of the Chest. 4th ed. Philadelphia, PA: WB Saunders; 1983.
    1. Bessone L, Ferguson T, Burford T. Chylothorax: a collective review. Ann Thorac Surg. 1971;12:527–550.
    1. Hamm H, Pfalzer B, Fabel H. Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis. Respiration. 1991;58:294–300.
    1. Ferguson G. Cholesterol pleural effusion in rheumatoid lung disease. Thorax. 1966;21:577–582.
    1. Meigs JV, Cass JW. Fibroma of the ovary with ascites and hydrothorax. Am J Obstet Gynecol. 1937;33:249–267.
    1. Samanth KK, Black WC., III Benign ovarian stromal tumors associated with free peritoneal fluid. Am J Obstet Gynecol. 1970;107:538–545.
    1. Bachman AL, Macken K. Pleural effusions following supervoltage radiation for breast carcinoma. Radiology. 1959;72:699–709.
    1. Farber JE, Lincoln NS. The unexpandable lung. Statement of the problem. Am Rev Tuberc. 1939;40:704–709.
    1. Mitrouska I, Bouros D. The trans-exudative pleural effusions. Chest. 2002;122:1503–1505.
    1. Zhou Q, Ye ZJ, Su Y, Zhang JC, Shi HZ. Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis. Heart. 2010;96:1207–1211.
    1. Albert WM, Salem AJ, Solomon DA, Boyce G. Hepatichydrothorax – cause and management. Arch Intern Med. 1991;151:2383–2388.
    1. Chen A, Yat-Sen H, Yen-Chang T, Hung-Shang T, TungChao C. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of the liver. J Clin Gastroenterol. 1988;10:663–666.
    1. Kakizaki S, Katakai K, Yoshinaga T, et al. Hepatic hydrothorax in the absence of ascites. Liver. 1998;18:216–220.
    1. Gurung P, Goldblatt M, Huggins JT, Doelken P, Nietert PJ, Sahn SA. Pleural fluid analysis and radiographic, sonographic, and echocardiographic characteristics of hepatic hydrothorax. Chest. 2011;140:448–453.
    1. Rudnick MR, Coyle JF, Beck LH, McCurdy DK. Acute massive hydrothorax complicating dialysis. Report of 2 cases and a review of the literature. Clin Nephrol. 1979;12:38–44.
    1. Adam WR, Arkles LB, Gilli G, Meagher E, Thomas GW. Hydrothorax with peritoneal dialysis: radionucleotide detection of a pleuroperitoneal connection. Aust N Z J Med. 1980;10:330–332.
    1. Stark DD, Shanes JG, Baron RL, Koch DD. Biochemical features of urinothorax. Arch Intern Med. 1982;142:1509–1511.
    1. Cavina C, Vicni G. Radiological aspects of pleural effusions in medical nephropathy in children. Ann Radiol Diagn (Bologna) 1958;31:163–202. Italian.
    1. Ito T, Engle MA, Goldberg HP. Postpericardiotomy syndrome following surgery for non-rheumatic heart disease. Circulation. 1958;17:549–556.
    1. Dressler W. A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. JAMA. 1956;160:1379–1383.
    1. Sklaroff HJ. Post-pulmonary infarction syndrome. Am Heart J. 1979;98:722–726.
    1. Bajaj BPS, Evans KE, Thomas P. Postpericardiotomy syndrome following temporary and permanent transvenous pacing. Postgrad Med J. 1999;75:357–358.
    1. Loughlin V, Murphy A, Russell C. The post-pericardiotomy syndrome and penetrating injury of the chest. Injury. 1987;18:412–414.
    1. Khan AH. The postcardiac injury syndromes. Clin Cardiol. 1992;15:67–72.
    1. Cohen M, Sahn SA. Resolution of pleural effusions. Chest. 2001;119:1547–1562.
    1. Robinson BWS, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax. 1981;36:896–900.
    1. Chertow BS, Kadzielawa R, Burger AJ. Benign pleural effusions in long-standing diabetes mellitus. Chest. 1991;99:1108–1111.
    1. Sachdev Y, Hall R. Effusions into body cavities in hypothyroidism. Lancet. 1975;1:564–566.
    1. Wier-Kronish JP, Broaddus VC, Albertine KH, Gropper, Mathway MA, Staub NC. Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. J Clin Invest. 1988;82:1422–1429.
    1. Lai-Fook SJ. Mechanics of the pleural space: fundamental concepts. Lung. 1987;165:249–267.
    1. Heffner JE, Sahn SA. Pleural disease in pregnancy. Clin Chest Med. 1992;13:667–678.
    1. Stark P, Pollack MS. Pleural effusions in the postpartum period. Radiology. 1986;26:471–475.
    1. Engel ME, Matchaba PT, Volmin J. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. 2007;4:CD001876.
    1. Dhebri AR, Ferran N. Nonsurgical management of pancreaticopleural fistula. J Pancreas. 2005;51:1–6.
    1. Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006;73:1211–1220.
    1. Light RW. Diagnostic principles in pleural disease. Eur Respir J. 1997;10:476–481.
    1. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J. Management of malignant pleural effusions. Eur Respir J. 2001;18:402–419.
    1. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56–64.
    1. Cardillo G, Facciolo F, Carbone L, Regal M, Corzani F, Ricci A. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg. 2002;21:302–305.
    1. Trotter D, Aly A, Siu L, Knight S. Video-assisted thoracoscopic pleurodesis for malignant effusion: an Australian teaching hospital’s experience. Heart Lung Circ. 2005;14:93–97.
    1. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence based guideline. Chest. 2000;118:1158–1171.
    1. Mulvey RB. The effect of pleural fluid on the diaphragm. Radiology. 1965;84:1080–1086.
    1. Estenne M, Yerrault JC, de Troyer A. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med. 1983;74:813–819.
    1. Perpina M, Benlloch E, Marco V, Abad F, Nauffal D. Effect of thoracocentesis on pulmonary gas exchange. Thorax. 1983;38:747–750.
    1. Matthews HR, McGuigan JA. Closed chest drainage without an underwater seal. Thorax. 1988;41:804P.
    1. Joshi JM. Intercostal tube drainage of pleura: Urosac as a chest drainage bag. J Assoc Physicians India. 1996;44:381–382.
    1. Sudduth C, Sahn SA. Pleurodesis for nonmalignant pleural effusions: recommendations. Chest. 1992;102:1855–1860.
    1. Vargas FS, Milanez JRC, Filomeno LTB, Fernandez A, Jatene A, Light RW. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest. 1994;106:1771–1775.
    1. Molnar TF. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg. 2007;32:422–430.
    1. Neff CC, Van Sonnenberg E, Lawson DW, Patten AS. CT follow up of empyema: pleural peels resolve after percutaneous catheter drainage. Radiology. 1990;176:195–197.
    1. Jain SK, Gupta P, Swaroo K. Conservative management of BPF. Ind J Chest Dis. 1975;17:79–84.
    1. Petty TL, Filley GF, Mitchell RS. Objective functional improvement by decortication after 20 years of artificial pneumothorax for pulmonary tuberculosis. Am Rev Respir Dis. 1961;84:572–578.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner